PDS Biotech to Host KOL Event on PDS0301 for Colorectal Cancer

PDS Biotechnology Corporation will host a virtual Key Opinion Leader (KOL) event on October 15, 2026, to discuss PDS0301 for the treatment of advanced colorectal cancer with liver metastases. The event will feature Jonathan M. Hernandez, M.D.